|Bid||0.0150 x 93500|
|Ask||0.0300 x 89900|
|Day's Range||0.0010 - 0.0010|
|52 Week Range||0.0005 - 1.8500|
|Beta (3Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Feb. 26) AstraZeneca plc (NYSE: AZN )(announced positive results ...
Index (PMI) data, output in the Healthcare sector is rising. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.
The problem doesn’t appear to have been the stigma around talking about bowel movements — an issue Synergy hoped to address with those (animated!) emojis — but rather a highly competitive market.(2)Trulance has made little headway against better established drugs like Allergan PLC’s Linzess and Takeda Pharmaceutical Co.’s Amitiza.
Synergy Pharma (SGYP) delivered earnings and revenue surprises of -7.69% and -29.04%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?
On a per-share basis, the New York-based company said it had a loss of 14 cents. The biopharmaceutical company posted revenue of $11.1 million in the period. In the final minutes of trading on Thursday, ...
The revelation that this biotech may be on borrowed time is a great reminder to investors to analyze balance sheets.
Shares collapse after management provides investors with a series of troubling business updates. Here's the must-know information for shareholders.
Investors need to pay close attention to Synergy Pharmaceuticals (SGYP) stock based on the movements in the options market lately.
If you want to know who really controls Synergy Pharmaceuticals Inc (NASDAQ:SGYP), then you’ll have to look at the makeup of its share registry. Large companies usually have institutions asRead More...